News Stories

Susan Pitt and Lisa Quale

While Tucsonans often brag about enjoying so many sunny days a year, all that sunshine can take a toll, sometimes in the form of skin cancer. The Arizona Cancer Center provides enhanced education and training for skin cancer patients and high-risk individuals through a patient education program.

Dr. Clara Curiel and Lynne Morrison use the SciBase.

Imagine an automated diagnostic device that can determine whether a suspicious mole is dangerous without doing a biopsy. Swedish company SciBase has created a device that aims to do just that and it is being tested in a clinical trial at the Arizona Cancer Center.

A $2 million gift from the Del E. Webb Foundation of Prescott will support recruiting and hiring faculty and staff members for the Arizona Cancer Center at Phoenix.

Sherif Morgan, PhD

Sherif Morgan, PhD, a research associate working with Lee Cranmer, MD, PhD, in the Arizona Cancer Center's Melanoma/Sarcoma Research Program, presented his research findings at the 22nd European Organisation for Research and Treatment of Cancer symposium.

AZCC researcher Jiaqi Shi, MD, PhD, has been awarded the pretigious Benjamin Castleman Award for her research in pancreatic cancer biomarkers and therapeutic targets.

Emmanuelle J. Meuillet, PhD

Colon cancer is a disease that can be prevented, treated and cured. But it takes action on your part.

David S. Alberts, MD

David S. Alberts, MD, director of the Arizona Cancer Center, will participate in the American Society of Preventive Oncology annual meeting in Las Vegas March 5 to 8.

An Arizona Cancer Center researcher has received a $3 million federal grant to study whether a compound in cruciferous vegetables, such as broccoli, can enhance the effects of a breast cancer drug.

Tom “Haggy” Hagedorn was a celebrated tennis coach, friend and husband. When his young life was claimed by leukemia in 2009, his wife Melissa established the Tom Hagedorn Foundation to make a difference in the fight against cancer.

Donna D. Zhang, PhD

Professor Donna Zhang and her team showed that brusatol, together with chemotherapy treatment, can combat chemoresistance, increase cell death, reduce cell proliferation and reduce tumor growth.